首页 正文

Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs

{{output}}
At the beginning of 2011, the early benefit assessment of new drugs was introduced in Germany with the Act on the Reform of the Market for Medicinal Products (AMNOG). The Federal Joint Committee (G-BA) generally commissions the Institute for Quality and Effici... ...